Cullinan Therapeutics, Inc. (CGEM)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
12. 93
-1.07
-7.6429%
$
954.44M Market Cap
- P/E Ratio
- Div Yield
1.12M Volume
- Eps
$ 14
Previous Close 
Want to track CGEM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cullinan Therapeutics, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Robert Driscoll Wedbush | 4,062.09 | $60,159.61 | $54,143.65 | -$6,015.96 | -10% |
2026 © Marketlog. All Rights Reserved.
